Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 760 results for "Tecfidera"

Forward Pharma Sues Biogen Idec Over Tecfidera(R) Sales in Germany

Forward Pharma Files Lawsuit Against Biogen Over Tecfidera Sal...

Forward Pharma A/S (FWP: Quote) said Tuesday it has filed a lawsuit against Biogen Idec GmbH, Biogen Idec International GmbH and Biogen Idec Ltd (BIIB) in the Regional Court in Dusseldorf, alleging infringement of its German utility model DE 20 2005 ..., 5 days ago

11 images for Tecfidera

EuroInvestor, 5 days ago
Lawyers & Settlements, 1 month ago
Seeking Alpha, 3 weeks ago
Citybizlist, 1 month ago
Nasdaq, 1 month ago
Boston Globe, 1 month ago
Boston Globe, 1 month ago
Yahoo! News, 1 month ago
CNBC, 1 month ago
Reuters India, 1 month ago
Seeking Alpha

Biogen: Nothing To Worry About

Summary Tecfidera's sales grew 175% since the same period last year. Tecfidera's future outlook is positive since the drug's efficacy is better than its competitors and the market for multiple sclerosis is growing. Multiple Sclerosis affects ...
 Seeking Alpha3 weeks ago Biogen Falls On Patient's Death  Bidness Etc1 month ago Biogen Falls After Patient Taking Top-Selling Tecfidera Dies  Washington Post1 month ago Hot Biogen shares fall after Tecfidera patient dies  CNBC1 month ago
Boston Globe

Biogen Idec reports death of patient that had taken its multiple sclerosis pill Tecfidera

Biogen Idec Inc. said Wednesday that a patient who had taken its multiple sclerosis pill Tecfidera for more than four years died after getting a rare brain infection, sending shares of the Cambridge biotechnology company falling on the Nasdaq stock ...
 Boston Globe1 month ago Biogen Retreats After Tecfidera Sales Miss, Patient Death Reported  TheStreet.com1 month ago Biogen shares drop on Tecfidera patient death  Town Hall1 month ago Health Exchange: Biogen shares drop on Tecfidera patient death  Austin American Statesman1 month ago
European Medicines Agency

Inform Patients of PML Case With Tecfidera in MS

The European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) is advising physicians to inform their patients about a fatal case of progressive multifocal leukoencephalopathy (PML) in a patient being treated with dimethyl ...
 Medscape2 weeks ago News and press releases: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 November 2014  European Medicines Agency2 days ago Highlights of EMA Pharmacovigilance unit meeting  Pharma Letter1 week ago

Biogen Falls on Concerns Regarding Tecfidera Sales and PML Case

Despite posting better-than-expected earnings, Biogen Idec's ( BIIB ) shares fell 5.4% immediately after the release of third quarter results. Although shares recovered slightly in the subsequent trading session, the overall decline is approximately ...
 Yahoo! Finance1 month ago

Dimethyl fumarate (Tecfidera) and PML

22 October 2014 Author: Someone has died with the brain infection PML whilst taking dimethyl fumarate (Tecfidera) to treat MS. The person had lymphopenia, which reduces the number of white blood cells and the body's ability to control the ...
 Multiple Sclerosis Trust1 month ago BRIEF-Biogen confirms one case of PML in patient taking MS drug Tecfidera  Reuters1 month ago Case of PML confirmed in someone taking Tecfidera  Noodls1 month ago

Biogen Falls After Patient on Top-Selling Drug Dies

Shares of Biogen Idec Inc. The patient, who died from pneumonia, is the first using Tecfidera to develop the brain infection known as progressive multifocal leukoencephalopathy, or PML, Chief Executive Officer George Scangos said on a call today.
 BusinessWeek1 month ago Biogen Idec Slumps After Patient On Top-Selling Drug Dies  BioSpace1 month ago

Biogen's Tecfidera Safety Fears Overblown, but Highlight a Real Life Cycle Management Risk

We don't recognize that email. Please try again. Forgot Password? Password Please enter your password. The password you entered does not match our records. Please try again. Our records show you have a Morningstar account, but you are not ...
 Morningstar.com1 month ago
Gulf Times

Biogen profit surges, but Tecfidera sales shy of Street view

Oct 22 (Reuters) - Biogen Idec Inc on Wednesday reported much higher third-quarter profit and revenue, even as its big-selling new oral multiple sclerosis drug Tecfidera fell short of lofty Wall Street estimates for the first time. Tecfidera, ...
 CNBC1 month ago Biogen profit surges; Tecfidera sales disappoint  Austin American Statesman1 month ago Biogen Profit Surges, Tecfidera Disappoint  FOXBusiness.com1 month ago UPDATE 2-Biogen quarterly profit surges, but Tecfidera sales disappoint  CNBC1 month ago

IPO Preview: Forward Pharma A/S

Summary Initiating a Phase 3 clinical trial for multiple sclerosis. Key competitor is Biogen. Biogen's Tecfidera® was approved by the FDA for the treatment of RRMS on March 27, 2103. Tecfidera® generated global sales of $2.08 billion from ...
 Seeking Alpha1 month ago Forward Pharma goes backward: year's largest biotech drops 17% on IPO  Nasdaq1 month ago IPO Stock Watch: Biotech Forward Pharma Falls On IPO  Investor's Business Daily1 month ago Forward Pharma pulls off a $221M IPO with eyes on unseating Biogen  FierceBiotech1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less